What is NDC 0338-9647?

0338-9647 is the product NDC for Vasopressin in 0.9% Sodium Chloride, Vasopressin 40 [USP'U]/100mL injection, listed with the FDA by Baxter Healthcare Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.

Baxter Healthcare Corporation, NDC labeler code 0338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Vasopressin in 0.9% Sodium Chloride?

3 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Vasopressin in 0.9% Sodium Chloride NDC 0338-9647

NDC codes

FDA NDC Directory

Product NDC (as listed)0338-9647Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00338-9647Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0338-9647-12	00338964712	12 BAG in 1 CARTON (0338-9647-12) / 100 mL in 1 BAGMarketed from Sep 29, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vasopressin in 0.9% Sodium Chloride
Generic name (nonproprietary): vasopressin in 0.9% sodium chloride
Active ingredients: Vasopressin — 40 [USP'U]/100mL
Dosage form: Injection
Route: Intravenous
Labeler: Baxter Healthcare CorporationNDC labeler code 0338
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 217569
Marketing start: Sep 29, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Diuresis (Physiologic effect)Vasoconstriction (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 0338-9647_e5fb5b63-6f2e-4ebe-9a55-147a793e95ddSPL ID e5fb5b63-6f2e-4ebe-9a55-147a793e95ddSPL set ID b5b2c367-6b7e-40be-a296-c4632f3e783fRxCUI 2399907, 2591428UNII Y4907O6MFD

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400338964712 followed by a unit qualifier and the quantity

Package 00338-9647-12. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 21, 2025.

Indications (excerpt from the label)

Vasopressin in Sodium Chloride Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. Vasopressin in Sodium Chloride Injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0338-9647

What is NDC 0338-9647?: 0338-9647 is the product NDC for Vasopressin in 0.9% Sodium Chloride, Vasopressin 40 [USP'U]/100mL injection, listed with the FDA by Baxter Healthcare Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Vasopressin in 0.9% Sodium Chloride.
What is the active ingredient?: Vasopressin.
Who is the labeler?: Baxter Healthcare Corporation, NDC labeler code 0338. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Vasopressin in 0.9% Sodium Chloride?: 3 other product NDCs are listed under this name. See all Vasopressin in 0.9% Sodium Chloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Vasopressin in 0.9% Sodium Chloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Vasopressin in 0.9% Sodium Chloridevasopressin	Vasopressin .2 [USP'U]/mL	SolutionIntravenous	Long Grove Pharmaceuticals, LLC	81298-8552	81298-8552-03
Vasopressin in 0.9% Sodium Chloridevasopressin	Vasopressin .4 [USP'U]/mL	SolutionIntravenous	Long Grove Pharmaceuticals, LLC	81298-8554	81298-8554-03
Vasopressin in 0.9% Sodium Chloride	Vasopressin 20 [USP'U]/100mL	InjectionIntravenous	Baxter Healthcare Corporation	0338-9640	00338-9640-12

Other NDCs under NDA 217569

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 217569
Product	Strength	Form · route	Labeler	Product NDC
Vasopressin in 0.9% Sodium Chloride	Vasopressin 20 [USP'U]/100mL	InjectionIntravenous	Baxter Healthcare Corporation	0338-9640